
Representative · FL-23 · D
Current term Jan 3, 2025 – Jan 3, 2027 · In the House since Jan 3, 2023
Official websiteBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Periodic transaction reports required by the STOCK Act: purchases, sales, and exchanges of stocks, bonds, and similar assets over $1,000 by the member, a spouse, or a dependent child, due within 45 days of the transaction. Filers report a value range (a few enter an exact amount), not the price or number of shares. Reports are shown as filed. For stocks and funds with a ticker, “Price moves” shows the closing price after the trade, at disclosure, and since, with an estimate of what an amount you choose within the reported range would have gained or lost; these are estimates, not the filer’s actual results. Members who do not trade individual securities file none.
Reports filed since Jan 1, 2025 with the House Clerk, last checked Oct 23, 2026. Filings are linked to this member by the seat or chamber they held on the filing date and their name.
191 reported transactions in 12 electronically filed reports; latest filed Aug 27, 2026.
Periodic Transaction Report · filed Mar 6, 2025 · House Clerk
View original filingWest Pharmaceutical Services, Inc. Common StockWST
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 21 days after the trade. WST closed at $199.11 on Feb 13, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeFeb 14, 2025 | $214.73 | +7.84% | $628 gain missed | |
| Day of disclosureMar 6, 2025 | $232.76 | +16.9% | $1,352 gain missed | |
| 30 days afterMar 17, 2025 | $231.46 | +16.2% | $1,300 gain missed | |
| 90 days afterMay 14, 2025 | $206.69 | +3.81% | $305 gain missed | |
| Latest closeOct 20, 2026 | $388.78 | +95.3% | $7,622 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
| Transaction date | Owner | Asset | Type | Amount (as reported) | Notified / status | Prices | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025Filed 21 days later | Dependent child | West Pharmaceutical Services, Inc. Common StockWSTStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Sale | $1,001 - $15,000 | Notified Feb 28, 2025New | ||||||||||||||||||||||||||
Disclosed 21 days after the trade. WST closed at $199.11 on Feb 13, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
Periodic Transaction Report · filed Feb 10, 2025 · House Clerk
View original filingAbbott Laboratories Common StockABT
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $113.91 | +2.53% | $202 gain missed | |
| Day of disclosureFeb 10, 2025 | $131.31 | +18.2% | $1,455 gain missed | |
| 30 days afterFeb 14, 2025 | $130.61 | +17.6% | $1,405 gain missed | |
| 90 days afterApr 15, 2025 | $126.22 | +13.6% | $1,089 gain missed | |
| Latest closeOct 20, 2026 | $102.45 | −7.79% | $623 loss avoided |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Abbott Laboratories Common StockABT
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $113.91 | +2.53% | $202 gain missed | |
| Day of disclosureFeb 10, 2025 | $131.31 | +18.2% | $1,455 gain missed | |
| 30 days afterFeb 14, 2025 | $130.61 | +17.6% | $1,405 gain missed | |
| 90 days afterApr 15, 2025 | $126.22 | +13.6% | $1,089 gain missed | |
| Latest closeOct 20, 2026 | $102.45 | −7.79% | $623 loss avoided |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Abbott Laboratories Common StockABT
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $113.91 | +2.53% | $202 gain missed | |
| Day of disclosureFeb 10, 2025 | $131.31 | +18.2% | $1,455 gain missed | |
| 30 days afterFeb 14, 2025 | $130.61 | +17.6% | $1,405 gain missed | |
| 90 days afterApr 15, 2025 | $126.22 | +13.6% | $1,089 gain missed | |
| Latest closeOct 20, 2026 | $102.45 | −7.79% | $623 loss avoided |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
AbbVie Inc. Common StockABBV
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. ABBV closed at $171.35 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $173.70 | +1.37% | +$110 gain | |
| Day of disclosureFeb 10, 2025 | $190.34 | +11.1% | +$887 gain | |
| 30 days afterFeb 14, 2025 | $192.87 | +12.6% | +$1,005 gain | |
| 90 days afterApr 15, 2025 | $176.80 | +3.18% | +$254 gain | |
| Latest closeOct 20, 2026 | $289.08 | +68.7% | +$5,497 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
AbbVie Inc. Common StockABBV
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. ABBV closed at $171.35 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $173.70 | +1.37% | +$110 gain | |
| Day of disclosureFeb 10, 2025 | $190.34 | +11.1% | +$887 gain | |
| 30 days afterFeb 14, 2025 | $192.87 | +12.6% | +$1,005 gain | |
| 90 days afterApr 15, 2025 | $176.80 | +3.18% | +$254 gain | |
| Latest closeOct 20, 2026 | $289.08 | +68.7% | +$5,497 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Canadian National Railway Company Common StockCNI
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $101.99 | +1.29% | $103 gain missed | |
| Day of disclosureFeb 10, 2025 | $102.50 | +1.80% | $144 gain missed | |
| 30 days afterFeb 14, 2025 | $101.59 | +0.89% | $72 gain missed | |
| 90 days afterApr 15, 2025 | $98.46 | −2.21% | $177 loss avoided | |
| Latest closeOct 20, 2026 | $121.25 | +20.4% | $1,634 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Canadian National Railway Company Common StockCNI
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $101.99 | +1.29% | $103 gain missed | |
| Day of disclosureFeb 10, 2025 | $102.50 | +1.80% | $144 gain missed | |
| 30 days afterFeb 14, 2025 | $101.59 | +0.89% | $72 gain missed | |
| 90 days afterApr 15, 2025 | $98.46 | −2.21% | $177 loss avoided | |
| Latest closeOct 20, 2026 | $121.25 | +20.4% | $1,634 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Canadian National Railway Company Common StockCNI
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $101.99 | +1.29% | $103 gain missed | |
| Day of disclosureFeb 10, 2025 | $102.50 | +1.80% | $144 gain missed | |
| 30 days afterFeb 14, 2025 | $101.59 | +0.89% | $72 gain missed | |
| 90 days afterApr 15, 2025 | $98.46 | −2.21% | $177 loss avoided | |
| Latest closeOct 20, 2026 | $121.25 | +20.4% | $1,634 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Goldman Sachs Group, Inc.GS
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $612.99 | +1.17% | +$93 gain | |
| Day of disclosureFeb 10, 2025 | $650.53 | +7.36% | +$589 gain | |
| 30 days afterFeb 14, 2025 | $660.55 | +9.02% | +$721 gain | |
| 90 days afterApr 15, 2025 | $507.89 | −16.2% | −$1,294 loss | |
| Latest closeOct 20, 2026 | $884.81 | +46.0% | +$3,683 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Goldman Sachs Group, Inc.GS
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $612.99 | +1.17% | +$93 gain | |
| Day of disclosureFeb 10, 2025 | $650.53 | +7.36% | +$589 gain | |
| 30 days afterFeb 14, 2025 | $660.55 | +9.02% | +$721 gain | |
| 90 days afterApr 15, 2025 | $507.89 | −16.2% | −$1,294 loss | |
| Latest closeOct 20, 2026 | $884.81 | +46.0% | +$3,683 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Goldman Sachs Group, Inc.GS
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $612.99 | +1.17% | +$93 gain | |
| Day of disclosureFeb 10, 2025 | $650.53 | +7.36% | +$589 gain | |
| 30 days afterFeb 14, 2025 | $660.55 | +9.02% | +$721 gain | |
| 90 days afterApr 15, 2025 | $507.89 | −16.2% | −$1,294 loss | |
| Latest closeOct 20, 2026 | $884.81 | +46.0% | +$3,683 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
McKesson Corporation Common StockMCK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. MCK closed at $583.45 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $595.19 | +2.01% | +$161 gain | |
| Day of disclosureFeb 10, 2025 | $603.40 | +3.42% | +$274 gain | |
| 30 days afterFeb 14, 2025 | $593.69 | +1.76% | +$140 gain | |
| 90 days afterApr 15, 2025 | $692.86 | +18.8% | +$1,500 gain | |
| Latest closeOct 20, 2026 | $1,030.12 | +76.6% | +$6,125 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
McKesson Corporation Common StockMCK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. MCK closed at $583.45 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $595.19 | +2.01% | +$161 gain | |
| Day of disclosureFeb 10, 2025 | $603.40 | +3.42% | +$274 gain | |
| 30 days afterFeb 14, 2025 | $593.69 | +1.76% | +$140 gain | |
| 90 days afterApr 15, 2025 | $692.86 | +18.8% | +$1,500 gain | |
| Latest closeOct 20, 2026 | $1,030.12 | +76.6% | +$6,125 gain |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Merck & Company, Inc. Common StockMRK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $100.70 | +0.61% | $49 gain missed | |
| Day of disclosureFeb 10, 2025 | $86.40 | −13.7% | $1,094 loss avoided | |
| 30 days afterFeb 14, 2025 | $83.01 | −17.1% | $1,365 loss avoided | |
| 90 days afterApr 15, 2025 | $78.39 | −21.7% | $1,735 loss avoided | |
| Latest closeOct 20, 2026 | $148.30 | +48.2% | $3,854 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Merck & Company, Inc. Common StockMRK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $100.70 | +0.61% | $49 gain missed | |
| Day of disclosureFeb 10, 2025 | $86.40 | −13.7% | $1,094 loss avoided | |
| 30 days afterFeb 14, 2025 | $83.01 | −17.1% | $1,365 loss avoided | |
| 90 days afterApr 15, 2025 | $78.39 | −21.7% | $1,735 loss avoided | |
| Latest closeOct 20, 2026 | $148.30 | +48.2% | $3,854 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Merck & Company, Inc. Common StockMRK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (1)
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 sold |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $100.70 | +0.61% | $49 gain missed | |
| Day of disclosureFeb 10, 2025 | $86.40 | −13.7% | $1,094 loss avoided | |
| 30 days afterFeb 14, 2025 | $83.01 | −17.1% | $1,365 loss avoided | |
| 90 days afterApr 15, 2025 | $78.39 | −21.7% | $1,735 loss avoided | |
| Latest closeOct 20, 2026 | $148.30 | +48.2% | $3,854 gain missed |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Stryker Corporation Common StockSYK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (5)
Disclosed 26 days after the trade. SYK closed at $368.61 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $381.79 | +3.58% | +$286 gain | |
| Day of disclosureFeb 10, 2025 | $392.60 | +6.51% | +$521 gain | |
| 30 days afterFeb 14, 2025 | $385.18 | +4.50% | +$360 gain | |
| 90 days afterApr 15, 2025 | $346.80 | −5.92% | −$473 loss | |
| Latest closeOct 20, 2026 | $304.40 | −17.4% | −$1,394 loss |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
Stryker Corporation Common StockSYK
Stocks (including ADRs) [ST]
Held in: Morgan Stanley Active Assets (6)
Disclosed 26 days after the trade. SYK closed at $368.61 on Jan 15, 2025; changes are measured from that close.
| Point | Session | Close | Change | On $8,001 bought |
|---|---|---|---|---|
| Day after the tradeJan 16, 2025 | $381.79 | +3.58% | +$286 gain | |
| Day of disclosureFeb 10, 2025 | $392.60 | +6.51% | +$521 gain | |
| 30 days afterFeb 14, 2025 | $385.18 | +4.50% | +$360 gain | |
| 90 days afterApr 15, 2025 | $346.80 | −5.92% | −$473 loss | |
| Latest closeOct 20, 2026 | $304.40 | −17.4% | −$1,394 loss |
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack.
| Transaction date | Owner | Asset | Type | Amount (as reported) | Notified / status | Prices | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025Filed 26 days later | Member | Abbott Laboratories Common StockABTStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Abbott Laboratories Common StockABTStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Abbott Laboratories Common StockABTStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. ABT closed at $111.10 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | AbbVie Inc. Common StockABBVStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. ABBV closed at $171.35 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Member | AbbVie Inc. Common StockABBVStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. ABBV closed at $171.35 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Canadian National Railway Company Common StockCNIStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Canadian National Railway Company Common StockCNIStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Member | Canadian National Railway Company Common StockCNIStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. CNI closed at $100.69 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Member | Goldman Sachs Group, Inc.GSStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Goldman Sachs Group, Inc.GSStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Goldman Sachs Group, Inc.GSStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. GS closed at $605.92 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Member | McKesson Corporation Common StockMCKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. MCK closed at $583.45 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | McKesson Corporation Common StockMCKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. MCK closed at $583.45 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Merck & Company, Inc. Common StockMRKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Merck & Company, Inc. Common StockMRKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Member | Merck & Company, Inc. Common StockMRKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (1) | Sale | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. MRK closed at $100.09 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Stryker Corporation Common StockSYKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (5) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. SYK closed at $368.61 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||
| Jan 15, 2025Filed 26 days later | Dependent child | Stryker Corporation Common StockSYKStocks (including ADRs) [ST]Held in: Morgan Stanley Active Assets (6) | Purchase | $1,001 - $15,000 | Notified Jan 31, 2025New | ||||||||||||||||||||||||||
Disclosed 26 days after the trade. SYK closed at $368.61 on Jan 15, 2025; changes are measured from that close.
Estimates: filers report neither the price nor the number of shares, so the close stands in for the price paid or received. Closes are split-adjusted and exclude dividends. Prices from Marketstack. | |||||||||||||||||||||||||||||||